newsGilead has said that topline results for clinical recovery have…
30 April 2020 | By Victoria Rees (European Pharmaceutical Review)
Gilead has said that topline results for clinical recovery have been demonstrated in a Phase III trial of remdesivir, tested in COVID-19 patients.